BCM
DVAX

Blume Capital Management’s Dynavax Technologies DVAX Stock Holding History

Blume Capital Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-30
Closed -$1K – 220
2016
Q1 		$1K Hold
30
– – ﹤0.01% 237
2015
Q4 		$1K Hold
30
– – ﹤0.01% 234
2015
Q3 		$1K Hold
30
– – ﹤0.01% 237
2015
Q2 		$1K Hold
30
– – ﹤0.01% 237
2015
Q1 		$1K Hold
30
– – ﹤0.01% 279
2014
Q4 		$1K Hold
30
– – ﹤0.01% 288
2014
Q3 		$0 Hold
30
– – ﹤0.01% 193
2014
Q2 		$0 Hold
30
– – ﹤0.01% 215
2014
Q1 		$1K Hold
30
– – ﹤0.01% 230
2013
Q4 		$1K Buy
+30
New +$439 ﹤0.01% 257

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
GA
Glenhill Advisors New York $6.94M AUM 24.62% 1-Year Est. Return
AC
Amici Capital New York $257M AUM 4.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

Blume Capital Management's DVAX Position: Q2 2016 in Review

Blume Capital Management sold out of Dynavax Technologies (DVAX) in Q2 2016, closing a stake of 30 shares — an estimated $1K sold.

Blume Capital Management first reported a position in DVAX in Q4 2013 and held it in 10 quarters. The position peaked at $1K in Q1 2016. 121 funds tracked by Wall St. Rank hold DVAX as of Q2 2016.

  • Blume Capital Management reported no remaining Dynavax Technologies position as of Q2 2016 after selling out during the quarter.
  • Blume Capital Management sold 30 Dynavax Technologies shares in Q2 2016, an estimated $1K.
  • Blume Capital Management first reported a position in Dynavax Technologies in Q4 2013 and held it in 10 quarters.
  • Blume Capital Management's Dynavax Technologies position peaked at $1K in Q1 2016.
  • 121 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2016.

Based on Blume Capital Management's 13F filing for Q2 2016, filed 4 Aug 2016.